rs2421016
×
Entrez Id:
59338
Gene Symbol:
PLEKHA1
PLEKHA1
Diabetes Mellitus, Non-Insulin-Dependent
T
0.800
GeneticVariation
GWASCAT
Genome-wide association analyses identify 143 risk variants and putative regulatory mechanisms for type 2 diabetes.
30054458
2018
rs2421016
×
Entrez Id:
59338
Gene Symbol:
PLEKHA1
PLEKHA1
Diabetes Mellitus, Non-Insulin-Dependent
T
0.800
GeneticVariation
GWASCAT
Identification of new susceptibility loci for type 2 diabetes and shared etiological pathways with coronary heart disease.
28869590
2017
rs2421016
×
Entrez Id:
59338
Gene Symbol:
PLEKHA1
PLEKHA1
Diabetes Mellitus, Non-Insulin-Dependent
C
0.800
GeneticVariation
GWASCAT
Identification of new susceptibility loci for type 2 diabetes and shared etiological pathways with coronary heart disease.
28869590
2017
rs10510110
×
Entrez Id:
59338
Gene Symbol:
PLEKHA1
PLEKHA1
Diabetes Mellitus, Non-Insulin-Dependent
C
0.800
GeneticVariation
GWASCAT
Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility.
24509480
2014
rs10510110
×
Entrez Id:
59338
Gene Symbol:
PLEKHA1
PLEKHA1
Diabetes Mellitus, Non-Insulin-Dependent
C
0.800
GeneticVariation
GWASDB
Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility.
24509480
2014
rs2421016
×
Entrez Id:
59338
Gene Symbol:
PLEKHA1
PLEKHA1
Diabetes Mellitus, Non-Insulin-Dependent
C
0.800
GeneticVariation
GWASDB
Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility.
24509480
2014
rs1045216
×
Entrez Id:
59338
Gene Symbol:
PLEKHA1
PLEKHA1
Age related macular degeneration
0.730
GeneticVariation
BEFREE
PLEKHA1 958A/G polymorphism was associated with a decreased AMD risk (additive model: aOR=0.722, 95% CI=0.450-0.979, P=0.019; allele model: aOR=0.883, 95% CI=0.736-0.992, P=0.014), while all other polymorphisms were associated with an increased AMD risk (CX3CR1 839C/T, additive model: aOR=2.682, 95% CI=1.119-5.709, P=0.022, recessive model: aOR=2.729, 95% CI=1.141-6.048, P=0.010; CX3CR1 745G/A, additive model: aOR=2.614, 95% CI=1.231-6.012, P=0.020, recessive model: aOR=2.340, 95% CI=1.227-5.993, P=0.011; VEGFA +674C/T, additive model: aOR=1.601, 95% CI=1.253-2.179, P<0.001, dominant model: aOR=1.287, 95% CI=1.058-1.570, P<0.001, allele model: OR=1.220, 95% CI=1.118-1.427, P<0.001; VEGFA +936C/T, additive model: aOR=1.509, 95% CI=1.105-2.311, P<0.001, recessive model: aOR=1.432, 95% CI=1.027-2.192, P=0.009, dominant model: aOR=1.207, 95% CI=1.031-1.514, P0.001, allele model: aOR=1.216, 95% CI=1.062-1.408, P<0.001).
29565837
2018
rs1045216
×
Entrez Id:
59338
Gene Symbol:
PLEKHA1
PLEKHA1
Age related macular degeneration
0.730
GeneticVariation
BEFREE
Using a panel of 8854 SNPs associated with AAMD at p-values ≤5.0E-7 from a cohort of >30,000 elderly people, we identified SNPs in miRNA target-encoding constituents of: (1) regulator of complement activation (RCA) genes (rs390679, CFHR1, p≤2.14E-214 ; rs12140421, CFHR3, p≤4.63E-29); (2) genes of major histocompatibility complex (MHC) loci (rs4151672, CFB, p≤8.91E-41 ; rs115404146, HLA-C, p≤6.32E-12 ; rs1055821, HLA-B, p≤1.93E-9 ; rs1063355, HLA-DQB1, p≤6.82E-14); and (3) genes of the 10q26 AAMD locus (rs1045216 , PLEKHA1, p≤4.17E-142 ; rs2672603, ARMS2, p≤7.14E-46).
28343170
2017
rs1045216
×
Entrez Id:
59338
Gene Symbol:
PLEKHA1
PLEKHA1
Age related macular degeneration
0.730
GeneticVariation
BEFREE
CX3CR1 (T280M and V249I) and PLEKHA1 (A320T ) polymorphisms were not found to be associated with AMD .
25050486
2014
rs1045216
×
Entrez Id:
59338
Gene Symbol:
PLEKHA1
PLEKHA1
Age related macular degeneration
0.730
GeneticVariation
GWASDB
Insights into the genetic architecture of early stage age-related macular degeneration: a genome-wide association study meta-analysis.
23326517
2013
rs4146894
×
Entrez Id:
59338
Gene Symbol:
PLEKHA1
PLEKHA1
Age related macular degeneration
0.710
GeneticVariation
GWASDB
Insights into the genetic architecture of early stage age-related macular degeneration: a genome-wide association study meta-analysis.
23326517
2013
rs4146894
×
Entrez Id:
59338
Gene Symbol:
PLEKHA1
PLEKHA1
Age related macular degeneration
0.710
GeneticVariation
BEFREE
Polymorphisms rs4146894 :G>A of Pleckstrin Homology Domain-containing Protein Family A member 1 (PLEKHA1) gene, rs10490924:G>T at LOC387715, and rs11200638:G>A of HTRA1 (HTRA serine peptidase 1) gene were analyzed in AMD cases (n=118, age=72.3+/-3.8 years old) and healthy controls (n=116, age=72.0+/-3.8 years old).
18079691
2007
rs11200607
×
Entrez Id:
59338
Gene Symbol:
PLEKHA1
PLEKHA1
Lean body mass
0.700
GeneticVariation
GWASCAT
Genomics of body fat percentage may contribute to sex bias in anorexia nervosa.
30593698
2019
rs2280141
×
Entrez Id:
59338
Gene Symbol:
PLEKHA1
PLEKHA1
Body Height
0.700
GeneticVariation
GWASCAT
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
30595370
2019
rs2292626
×
Entrez Id:
59338
Gene Symbol:
PLEKHA1
PLEKHA1
Birth Weight
T
0.700
GeneticVariation
GWASCAT
Maternal and fetal genetic effects on birth weight and their relevance to cardio-metabolic risk factors.
31043758
2019
rs2292626
×
Entrez Id:
59338
Gene Symbol:
PLEKHA1
PLEKHA1
Body Height
0.700
GeneticVariation
GWASCAT
Characterizing rare and low-frequency height-associated variants in the Japanese population.
31562340
2019
rs3850765
×
Entrez Id:
59338
Gene Symbol:
PLEKHA1
PLEKHA1
Hypothyroidism
0.700
GeneticVariation
GWASCAT
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
30595370
2019
rs4752693
×
Entrez Id:
59338
Gene Symbol:
PLEKHA1
PLEKHA1
Systolic Pressure
0.700
GeneticVariation
GWASCAT
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
30595370
2019
rs7072204
×
Entrez Id:
59338
Gene Symbol:
PLEKHA1
PLEKHA1
Diabetes Mellitus, Non-Insulin-Dependent
A
0.700
GeneticVariation
GWASCAT
Identification of 28 new susceptibility loci for type 2 diabetes in the Japanese population.
30718926
2019
rs7088058
×
Entrez Id:
59338
Gene Symbol:
PLEKHA1
PLEKHA1
AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET, 2
0.700
GeneticVariation
GWASCAT
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
30595370
2019
rs7088058
×
Entrez Id:
59338
Gene Symbol:
PLEKHA1
PLEKHA1
AUTOIMMUNE DISEASE, SUSCEPTIBILITY TO, 6
0.700
GeneticVariation
GWASCAT
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
30595370
2019
rs7088058
×
Entrez Id:
59338
Gene Symbol:
PLEKHA1
PLEKHA1
AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET, 1
0.700
GeneticVariation
GWASCAT
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
30595370
2019
rs7088058
×
Entrez Id:
59338
Gene Symbol:
PLEKHA1
PLEKHA1
Autoimmune Diseases
0.700
GeneticVariation
GWASCAT
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
30595370
2019
rs71486610
×
Entrez Id:
59338
Gene Symbol:
PLEKHA1
PLEKHA1
Birth Weight
C
0.700
GeneticVariation
GWASCAT
Maternal and fetal genetic effects on birth weight and their relevance to cardio-metabolic risk factors.
31043758
2019
rs78438709
×
Entrez Id:
59338
Gene Symbol:
PLEKHA1
PLEKHA1
Headache
G
0.700
GeneticVariation
GWASCAT
A Genome-Wide Association Study Finds Genetic Associations with Broadly-Defined Headache in UK Biobank (N=223,773).
29397368
2018